Author:
REN Zhitao,XIAO Gemin,CHEN Yixin,WANG Linli,XIANG Xiaoxin,YANG Yi,WEN Siying,XIE Zhiyong,LUO Wenhui,LI Guowei,ZHENG Wenhua,QIAN Xiaoxian,HAI Rihan,YANG Liansheng,ZHU Yanhua,CAI Mengyin,YE Yinong,SHI Guojun,CHEN Yanming
Subject
Complementary and alternative medicine,Drug Discovery,General Medicine
Reference26 articles.
1. Obesity prevalence and risks among Chinese adults: findings from the China PEACE Million Persons Project, 2014−2018;Mu;Circ Cardiovasc Qual Outcomes,2021
2. Nonalcoholic fatty liver disease 2020: the state of the disease;Cotter;Gastroenterology,2020
3. Changing clinical management of NAFLD in Asia;Nakatsuka;Liver Int,2021
4. Obesity and nonalcoholic fatty liver disease: from pathophysiology to therapeutics;Polyzos;Metabolism,2019
5. Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor alpha;Cui;Chin J Nat Med,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献